Search
for
Sort by
Research 211–240 of 1000+
- Large-Scale Plasma Proteomics and Genetic Integration Uncover Novel Biological Pathways in Male Pattern Baldness
- Prolactin as a candidate sebotrop(h)ic hormone?
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- 11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
- Androgenetic Alopecia: A Review
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- Androgen replacement therapy in women
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
- Nonclassic adrenal hyperplasia
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
- Cutaneous manifestations of polycystic ovary syndrome
- Androgenic disorders
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- An adolescent girl with coexisting ovarian mature cystic teratoma and HAIR-AN syndrome, an extreme subtype of polycystic ovarian syndrome
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
- What is the Rationale for Androgen Therapy for Women?
- Metabolic Syndrome in Androgenetic Alopecia in a Tertiary Care Centre in Goa: A Case Control Study During COVID-19 Pandemic
- Targets to treat androgen excess in polycystic ovary syndrome
- Androgen effects on the skin
- Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp
- Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats